Amarin Corp Plc (AMRN)

[Whalatane]

https://www.practicalcardiology.com/view/early-aspirin-use-could-lower-mortality-odds-of-stroke-in-covid-19?utm_source=sfmc&utm_medium=email&utm_campaign=03262022_PCAMA-21-PCV0101_eNL_Amarin%20Vascepa%20Promo_LeadGen_Gentem&eKey=Z2FyeWhlYWRuekBnbWFpbC5jb20=

Note. “This study suggests that early aspirin use may be associated with lower odds of in-hospital mortality among hospitalized patients with moderate COVID-19; these findings warrant further study in a randomized clinical trial that includes diverse patients with cardiovascular comorbidities,” investigators explained.

Well on April 3rd we will have MITIGATE results ...a randomized clinical trial that includes diverse patients with cardiovascular comorbidities
.
If aspirin works in this population ...Vascepa should work even better
Just my guess
NNT ( numbers needed to treat ) for cardio risk reduction using aspirin is something like 254
NNT for cardio risk reduction can be as low as 12 with Vascepa
Kiwi